• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Creative Bio-Peptides Inc.

Creative Bio-Peptides Inc.

  • Home
  • Company
    • Our Company
    • Our People
  • Science
    • Introduction
    • RECEPTIDES
    • Publications
  • Therapy Areas
    • Persistent Post-Surgical Pain
    • Parkinson’s Disease
    • Opioid Use Disorders
  • News
  • Contact
  • LinkedIn

Publications

Selected Pre-Clinical Studies:

  • Rosi S, Pert CB, Ruff MR, McGann-Gramling K, Wenk GL. Chemokine receptor 5 antagonist D-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer’s disease. Neuroscience; 134, 671-676.
  • Padi SS, Shi XQ, Zhao YQ et al. Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103, which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation. Pain; 153, 95-106.
  • 2017, Ruff, MR   Virobiome derived Peptide T: Anti-inflammatory peptides for treating neuro-AIDS and neurodegenerative diseases.

List of all pre-clinical publications, with LINKS

 

Selected Clinical Studies:

  • Villemagne VL, Phillips RL, Liu X et al. Peptide T and glucose metabolism in AIDS dementia complex. J Nucl Med; 37, 1177-1180.
  • Heseltine PN, Goodkin K, Atkinson JH et al. Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment. Arch Neurol; 55, 41-51.
  • Barbey-Morel C, McDonnell K, Pert C et al. A Peptide T Bolus Normalizes Growth Hormone Secretion Pattern in Two Children with AIDS. Peptides; 6538, 1-3.

List of all clinical publications, with LINKS

 

 

Primary Sidebar

Latest News

  • RAP-103 Inhibits Opioid-derived Dependence, Withdrawal and Respiratory Depression  Jul 19, 2022
  • RAP-103 Benefits in Pain Published Jul 14, 2022
  • BioHealth Innovation Press Release Features Creative Bio-Peptides Nov 30, 2021
  • A Conversation with CBO Michael Simon Apr 8, 2021
  • NIH SBIR AWARD FOR SYNAPSE PROTECTING TREATMENTS FOR ALZHEIMER’S DISEASE Sep 28, 2020
  • CREATIVE BIO-PEPTIDES RECEIVES NIH HEAL AWARD FOR OPIOID ABUSE DISORDERS Jan 20, 2020
  • CREATIVE BIO-PEPTIDES and LEIDOS AWARDED US DOD CONTRACT Jan 18, 2020

Read more news

Footer

Creative Bio-Peptides Inc.

Rockville, MD
USA  20854

  • LinkedIn

  • RAP-103 Inhibits Opioid-derived Dependence, Withdrawal and Respiratory Depression  Jul 19, 2022
  • RAP-103 Benefits in Pain Published Jul 14, 2022
  • BioHealth Innovation Press Release Features Creative Bio-Peptides Nov 30, 2021
  • A Conversation with CBO Michael Simon Apr 8, 2021
  • NIH SBIR AWARD FOR SYNAPSE PROTECTING TREATMENTS FOR ALZHEIMER’S DISEASE Sep 28, 2020
  • CREATIVE BIO-PEPTIDES RECEIVES NIH HEAL AWARD FOR OPIOID ABUSE DISORDERS Jan 20, 2020
  • CREATIVE BIO-PEPTIDES and LEIDOS AWARDED US DOD CONTRACT Jan 18, 2020

Read more news

Copyright © 2023 Creative Bio-Peptides Inc.